Welcome to our dedicated page for Iperionx SEC filings (Ticker: IPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IperionX Limited filings document foreign private issuer reports, operating updates, governance actions, and market disclosures for a Nasdaq and ASX-listed titanium technology company. Form 6-K exhibits include quarterly reports on titanium powder production and component manufacturing, shareholder letters, investor presentations, meeting materials, ASX correspondence, and notices of company secretary and registered-office changes.
The filings describe the company’s HAMR™ and HSPT™ technologies, Virginia Titanium Manufacturing Campus, Titan critical minerals project, U.S. Department of War grant programs, reimbursement mechanics, equipment procurement treatment, and customer-related manufacturing activity. Governance and ownership disclosures cover shareholder meeting results, equity incentive approvals, director and officer ownership changes, and communications between the company and ASX.
IPERIONX Ltd Chief Executive Officer Anastasios Arima reported an open-market purchase of 110,000 Ordinary Shares on April 28, 2026 at an average price of $4.4875 per share. Following this transaction, he directly holds 12,316,782 Ordinary Shares.
He also reports various equity incentives, including options over 639,205 Ordinary Shares at A$22 and 564,759 Ordinary Shares at A$18, plus multiple performance rights series and 128,000 American Depository Shares, each ADS being exchangeable into ten Ordinary Shares.
IPERIONX Ltd Executive Chairman Todd Hannigan reported significant open-market share purchases. On April 28, 2026, he bought 220,000 Ordinary Shares at an average price of $4.4819 per share, followed by another purchase of 260,000 Ordinary Shares at $4.1991 per share on April 29, 2026.
After these trades, he directly holds 26,108,334 Ordinary Shares, along with 454,464 Restricted Stock Units, 500,000 American Depository Shares, and several option and performance rights awards over additional Ordinary Shares. One ADS is exchangeable for 10 Ordinary Shares, highlighting a substantial overall equity exposure.
IperionX Limited reports a major step-up in operations, moving its Virginia titanium campus from commissioning to 24/7 continuous production using its HAMR™ and HSPT™ technologies. March HAMR™ powder output reached about 4.2 metric tons, an annualized rate of roughly 50 tpa, with a target of ~200 tpa by end of CY2026.
The company is expanding downstream press-and-sinter and additive manufacturing capacity to convert powders into higher-value titanium components for defense, automotive and consumer electronics customers. U.S. Department of War support now totals up to US$59.8 million in obligated grants plus an SBIR pathway of up to US$99 million, alongside 290 metric tons of scrap feedstock transferred at no cost.
As of March 31, 2026, IperionX held US$48.2 million cash, after a quarterly operating cash outflow of US$16.3 million, and estimates a June 30, 2026 cash balance of US$36–40 million. The Titan Critical Minerals Project DFS is nearing completion for mid‑2026, positioning Titan as a potential U.S. source of titanium, zircon and heavy rare earths.
IperionX Limited reports a major step-up in operations, moving its Virginia titanium campus from commissioning to 24/7 continuous production using its HAMR™ and HSPT™ technologies. March HAMR™ powder output reached about 4.2 metric tons, an annualized rate of roughly 50 tpa, with a target of ~200 tpa by end of CY2026.
The company is expanding downstream press-and-sinter and additive manufacturing capacity to convert powders into higher-value titanium components for defense, automotive and consumer electronics customers. U.S. Department of War support now totals up to US$59.8 million in obligated grants plus an SBIR pathway of up to US$99 million, alongside 290 metric tons of scrap feedstock transferred at no cost.
As of March 31, 2026, IperionX held US$48.2 million cash, after a quarterly operating cash outflow of US$16.3 million, and estimates a June 30, 2026 cash balance of US$36–40 million. The Titan Critical Minerals Project DFS is nearing completion for mid‑2026, positioning Titan as a potential U.S. source of titanium, zircon and heavy rare earths.
IPERIONX Ltd Chief Financial Officer Marcela Rocha Castro received new equity awards. She was granted options over 127,993 IPX Ordinary Shares at an exercise price of A$11 per share and 52,258 restricted stock units, both dated April 2, 2026.
Each option allows the purchase of one ordinary share at the stated conversion price. Following these awards, she directly holds 340,795 ordinary shares and 214,259 restricted stock units. Existing options with a conversion price of A$5 over IPX Ordinary Shares remain outstanding, and the restricted stock units vest on a schedule extending to April 2029.
IPERIONX Ltd President Toby Edgcumbe Symonds reported new equity awards and updated holdings. He received 226,047 performance rights tied to an A$18 share price hurdle and service conditions, plus 536,521 options at A$18 and 607,244 options at A$22, each over IPX ordinary shares. These are compensation-related grants, not market purchases or sales. After these awards, he reports direct ownership of 3,188,146 ordinary shares, 110,000 American Depositary Shares, and substantial additional performance rights and restricted stock units that may convert into ordinary shares if their conditions are met.
Arima Anastasios reported acquisition or exercise transactions in this Form 4 filing.
IPERIONX Ltd Chief Executive Officer Anastasios Arima received multiple new equity awards. On 2026-04-02, he was granted 237,944 performance rights tied to an A$18.00 stock-price hurdle and four years of continuous service, each convertible into one ordinary share once the performance criteria are met.
He was also granted options over 564,759 IPX ordinary shares at A$18.00 and 639,205 shares at A$22.00, each exercisable from 2030-04-02 and expiring on 2031-04-02. These are compensation-related awards, not open-market share purchases or sales.
Following these grants, Arima holds 12,206,782 ordinary shares directly, 128,000 American Depository Shares listed on Nasdaq (each equal to ten ordinary shares), 435,806 performance rights at each of A$6.00, A$7.00 and A$8.00, and 738,576 restricted stock units.
IPERIONX Ltd Executive Chairman Todd Hannigan received new equity awards in the form of performance rights and options linked to IPX Ordinary Shares. On April 2, 2026, he was granted 196,086 performance rights and 465,410 options each with an exercise price of A$18.00, plus 526,760 options with an exercise price of A$22.00.
Each performance right can convert into one ordinary share if service and stock price performance conditions are met, and each option allows purchase of one ordinary share at the stated price. Following these awards, he holds 25,628,334 Ordinary Shares directly, alongside existing derivative positions and 500,000 ADS representing IPX Ordinary Shares.
IPERIONX Ltd President Toby Edgcumbe Symonds made an open‑market purchase of 11,000 American Depository Shares (ADS) of IPERIONX at an average price of $23.8684 per ADS. Each ADS represents 10 ordinary shares traded on the Australian Stock Exchange.
After this transaction, he directly holds 11,000 ADS, 3,188,146 ordinary shares, and 703,199 Restricted Stock Units. He also holds performance rights over ordinary shares with exercise prices of A$4, A$6, A$7 and A$8, exercisable or expiring between December 2028 and April 2030.
IPERIONX Ltd director R. Tony Tripeny bought shares on the open market. He purchased 4,187 American Depository Shares at an average price of $23.7554 per ADS in an open‑market transaction. Following this purchase, he directly holds 4,187 ADS, 38,777 ordinary shares, and 51,010 restricted stock units. One ADS is convertible into 10 ordinary shares, and the RSUs are scheduled to vest in tranches of 36,848 in December 2026 and 14,162 in December 2027.